Engell Anna Elise, Bathum Lise, Siersma Volkert, Andersen Christen Lykkegaard, Lind Bent Struer, Jørgensen Henrik Løvendahl
Department of Clinical Biochemistry, Copenhagen University Hospital, Hvidovre, Denmark.
Department of Public Health, Section of General Practice and Research Unit for General Practice, University of Copenhagen, Copenhagen, Denmark.
Lipids Health Dis. 2025 May 24;24(1):189. doi: 10.1186/s12944-025-02607-5.
Hyperlipidemia is a well-established risk factor for cardiovascular disease and mortality. Recently, remnant cholesterol has been introduced as an important risk factor. This study explores the association between levels of remnant cholesterol, compared to the traditional lipid parameters (total cholesterol, low-density lipoprotein (LDL-C), high-density lipoprotein (HDL-C), non-high-density lipoprotein cholesterol (non-HDL-C) and triglycerides), and all-cause mortality in a population from general practice. Additionally, the impact of lipid-lowering treatment was evaluated.
Observational cohort study based on the first lipid panel measurement from 327,347 patients from general practice in the Capital Region of Denmark between 2001 and 2018. LDL-C was calculated using the Friedewald equation. Patients with diagnoses or medical treatments that affected lipid levels were excluded. Cox proportional hazards models with restricted cubic splines were used to evaluate the association between all-cause mortality and lipid levels.
A total of 34,014 patients died during the study. In an analysis censoring individuals receiving lipid lowering treatment after the lipid measurement, remnant cholesterol increased all-cause mortality risk linearly, with a hazard ratio (HR) of 1.6 (95% CI: 1.4; 1.7) at 3 mmol/L compared to a reference level of 0.9 mmol/L. Total cholesterol showed a U-shaped relationship with all-cause mortality with a HR of 2.5 (95% CI: 2.3; 2.7) at 2.5 mmol/L and 1.7 (95% CI: 1.6; 1.9) at 9 mmol/L (reference level 5 mmol/L). LDL-C and non-HDL-C exhibited a very similar U-shaped pattern. HDL-C also showed a U-shaped curve with a HR of 1.7 (95% CI: 1.6; 1.9) at 0.5 mmol/L and 1.4 (95% CI: 1.3; 1.5) at 3.5 mmol/L (reference level 1 mmol/L). The mortality risk related to triglycerides increased with rising triglyceride level, with a HR of 1.5 (95% CI: 1.3; 1.6) at 4.5 mmol/L (reference level 2 mmol/L).
In this study, high levels of all the six lipids as well as low levels of total cholesterol, LDL-C, non-HDL-C and HDL-C were associated with higher all-cause mortality in a primary health care population. Further research is needed, to consider if the current lipid lowering guidelines are appropriate and if more focus on remnant cholesterol levels should be applied.
高脂血症是心血管疾病和死亡的公认危险因素。最近,残留胆固醇已被视为一种重要的危险因素。本研究探讨了残留胆固醇水平与传统血脂参数(总胆固醇、低密度脂蛋白(LDL-C)、高密度脂蛋白(HDL-C)、非高密度脂蛋白胆固醇(非HDL-C)和甘油三酯)相比,与全科医疗人群全因死亡率之间的关联。此外,还评估了降脂治疗的影响。
基于2001年至2018年间丹麦首都地区327347名全科医疗患者的首次血脂检测结果进行观察性队列研究。使用Friedewald方程计算LDL-C。排除患有影响血脂水平的疾病或接受过相关治疗的患者。采用带有受限立方样条的Cox比例风险模型评估全因死亡率与血脂水平之间的关联。
研究期间共有34014名患者死亡。在一项对血脂检测后接受降脂治疗的个体进行截尾的分析中,残留胆固醇使全因死亡风险呈线性增加,与参考水平0.9 mmol/L相比,3 mmol/L时的风险比(HR)为1.6(95% CI:1.4;1.7)。总胆固醇与全因死亡率呈U形关系,2.5 mmol/L时HR为2.5(95% CI:2.3;2.7),9 mmol/L时为1.7(95% CI:1.6;1.9)(参考水平5 mmol/L)。LDL-C和非HDL-C呈现非常相似的U形模式。HDL-C也呈U形曲线,0.5 mmol/L时HR为1.7(95% CI:1.6;1.9),3.5 mmol/L时为1.4(95% CI:1.3;1.5)(参考水平1 mmol/L)。与甘油三酯相关的死亡风险随甘油三酯水平升高而增加,4.5 mmol/L时HR为1.5(95% CI:1.3;1.6)(参考水平2 mmol/L)。
在本研究中,在基层医疗人群中,所有六种血脂的高水平以及总胆固醇、LDL-C非HDL-C和HDL-C的低水平均与较高的全因死亡率相关。需要进一步研究,以考虑当前的降脂指南是否合适,以及是否应更多地关注残留胆固醇水平。